Quarterly report pursuant to Section 13 or 15(d)

Note 15 - Stock-based Compensation and Other Benefit Plans (Tables)

v3.23.1
Note 15 - Stock-based Compensation and Other Benefit Plans (Tables)
3 Months Ended
Mar. 31, 2023
Notes Tables  
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
   

Three Months Ended March 31,

 
   

2023

   

2022

 
   

(in thousands)

 

Stock-based compensation - equity awards

  $ 675     $ 404  

Stock-based compensation - liability awards

    (26 )     1,018  

Total stock-based compensation

  $ 649     $ 1,422  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   

Three Months Ended March 31,

 
   

2022

 

Weighted average exercise price - ($/share)

  $ 6.41  

Expected life in years

    6.0  

Average expected volatility

    72

%

Risk-free interest rate

    1.98

%

Expected dividend yield

    2.30

%

Weighted average grant date fair value - ($/share)

  $ 2.84  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
   

Number of Shares Underlying Options

   

Weighted Average Exercise Price Per Share

   

Weighted Average Remaining Contractual Term

   

Aggregate Intrinsic Value

 
   

(in thousands)

           

(in years)

   

(in thousands)

 

Outstanding at January 1, 2023

    444     $ 3.98                  

Granted

                           

Exercised

    (74 )     (1.68 )                

Unvested shares forfeited

                           

Vested shares expired

                           

Outstanding at March 31, 2023

    370     $ 4.40       8.30     $ 414  

Exercisable at March 31, 2023

    166     $ 3.91       8.15     $ 224  
   

Number of Shares Underlying Options

   

Weighted Average Exercise Price Per Share

   

Weighted Average Remaining Contractual Term

   

Aggregate Intrinsic Value

 
   

(in thousands)

           

(in years)

   

(in thousands)

 

Outstanding at January 1, 2023

    387     $ 1.86                  

Granted

                           

Exercised

    (99 )     (1.50 )                

Unvested shares forfeited

                           

Vested shares expired

                           

Outstanding at March 31, 2023

    288     $ 1.98       0.81     $ 732  

Exercisable at March 31, 2023

    288     $ 1.98       0.81     $ 732  
Nonvested Restricted Stock Shares Activity [Table Text Block]
   

Restricted Stock

   

Weighted Average Grant Date Fair Value

 
   

(in thousands)

         

Non-vested shares outstanding at January 1, 2023

    665     $ 4.59  

Awards granted

           

Awards vested

    (205 )     4.82  

Awards forfeited

           

Non-vested shares outstanding at March 31, 2023

    460     $ 4.49  
   

Restricted Stock

   

Weighted Average Conversion Date Fair Value

 
   

(in thousands)

         

Non-vested shares outstanding at January 1, 2023

    383     $ 4.27  

Awards granted

           

Awards vested

    (121 )     4.27  

Awards forfeited

    (23 )     4.27  

Non-vested shares outstanding at March 31, 2023

    239     $

4.27

 

Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]
   

Restricted Stock

   

Weighted Average Conversion Date Fair Value

 
   

(in thousands)

         

Non-vested shares outstanding at January 1, 2023

    690     $ 4.27  

Awards granted

           

Awards vested

    (134 )     4.27  

Awards forfeited

    (36 )     4.27  

Non-vested shares outstanding at March 31, 2023

    520     $ 4.27  
Share-Based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]
   

Number of Shares Underlying SARs

   

Weighted Average Exercise Price Per Share

   

Weighted Average Remaining Contractual Term

   

Aggregate Intrinsic Value

 
   

(in thousands)

           

(in years)

   

(in thousands)

 

Outstanding at January 1, 2023

    202     $ 1.87                  

Granted

                           

Exercised

    (63 )     0.86                  

Unvested SARs forfeited

                           

Vested SARs expired

                           

Outstanding at March 31, 2023

    139     $ 2.33       0.92     $ 304  

Exercisable at March 31, 2023

    139     $ 2.33       0.92     $ 304